Corrigendum to "Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features" [Modern Pathology 33 (2020) 496-513]

Priyadharsini Nagarajan ¹, Jin Piao ², Jing Ning ³

¹Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
²Department of Clinical Preventive Medicine, University of Southern California, Los Angeles, California; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands.
⁵Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁶Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
⁷Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁸Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁹Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹⁰Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹¹Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹²Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Now with Departments of Pathology and Laboratory Medicine, The University of California, San Francisco, San Francisco, California.

⁰Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc +

|

June 20, 2025

Summary

No abstract available on PubMed